'We have a problem with price rises': PSNC CEO answers your questions
From purchase profits to generics price hikes, the Pharmaceutical Services Negotiating Committee's (PSNC) outgoing CEO answered questions from C+D readers this week.
Ms Sharpe – who will be replaced by fraud prevention service CEO Simon Dukes in May – also fielded a reader question on Monday (January 15) about whether she would “stay on in any capacity” to support him.
Watch the video below to see Ms Sharpe’s responses, including her acknowledgement that drug price rises have “been a really big addition to the tremendous financial pressures pharmacists have had to bear over the last six months”.
During the same interview, Ms Sharpe explained how the current funding squeeze has left pharmacies with "a lot of debt" in "a really desperate position". Find out what else she discussed here.
What do you think PSNC's priorities should be in 2018?